Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...

Moderna (MRNA) closed at $34.01 in the latest trading session, marking a -1.9% move from the prior day. This change lagged the S&P 500's daily gain of 0.07%. Meanwhile, the Dow lost 0.7%, and the ...

Semiconductors are the picks and shovels of modern technology. The way we live and work is also changing with AI, which is ...

NXG offers a 13.8% yield but faces risks like leverage and high valuation. Learn about NXG CEF strategy and why waiting might ...

Moderna stock is indeed in the doldrums today, but this offers the opportunity to buy at a reasonable price, and, 10 years down the road, potentially benefit from a huge biotech growth story.

I have long believed in examining investment trends in a realistic light. My recent reflections on stock picking offer a ...

With bold reform and a clear strategic vision, Vietnam is positioning its stock market to become a key engine of growth and a regional financial hub by 2030.

The gold miners’ stocks are priming to run, nearing their next major surge higher. They’ve proven quite resilient this summer ...

1. Moderna It feels like ages ago that Moderna achieved monumental success thanks to its coronavirus-related vaccine work, but the company hasn't been sitting idly by since.

Elsewhere, if you missed it during Prime Day, you can still get the Fitbit Inspire 3 for a bargain price of £58.99 (was ...

Rolling-stock demand across South Africa and the African continent is surging, with freight locomotives, particularly ...